ZG005
ZG005-007
Phase 2 small_molecule active
Quick answer
ZG005 for Biliary Tract Carcinoma is a Phase 2 program (small_molecule) at Suzhou Zelgen Biopharmaceuticals Co.,Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Indication
- Biliary Tract Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active